Derek A. Mann

Koç University — Turkey

Medicine · Health Sciences

77h-index18.1kcitations341works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(84), Liver physiology and pathology(83), NF-κB Signaling Pathways(28), Epigenetics and DNA Methylation(21), Immune Response and Inflammation(17)

Publications339 total

Loss of p62 Binding Allows <scp>TIF</scp> ‐ <scp>IA</scp> Accumulation in Senescence, Which Promotes Phenotypic Changes to Nucleoli and the Senescence Associated Secretory Phenotype
Aging Cell·2025Open Access
Improving surgical treatments for hepatocellular carcinoma
Nature Reviews Gastroenterology & Hepatology·2025· 1 citedOpen Access
Comment on “Nivolumab plus ipilimumab for potentially resectable hepatocellular carcinoma: Long-term efficacy and biomarker exploration”
Journal of Hepatology·2025
Pathogenic germline variants in a racially diverse real-world cohort of prostate cancer patients
2025Open Access
Comment on “G-LERP/miR-374i-b Attenuates IRI and Suppresses Hepatocellular Carcinoma Progression”
Transplantation·2025
Clinical and molecular characterisation of primary refractoriness to atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma
2025Open Access
Precision-cut tumor slices for modeling hepatocellular carcinoma enable at-scale drug screening
Hepatology Communications·2025· 3 citedOpen Access
Chromosomal instability shapes the tumor microenvironment of esophageal adenocarcinoma via a cGAS–chemokine–myeloid axis
2025· 1 citedOpen Access
Spatial lipidomics reveals sphingolipid metabolism as anti-fibrotic target in the liver
Metabolism·2025· 12 citedOpen Access
Deciphering Novel Communication Patterns in T Regulatory Cells From Very Old Adults
Aging Cell·2025· 1 citedOpen Access
Pharmacological manipulation of liver fibrosis progression using novel <scp>HDAC</scp>6 inhibitors
FEBS Journal·2025· 2 citedOpen Access
Human-correlated genetic models identify precision therapy for liver cancer
Nature·2025· 17 citedOpen Access
Current Approaches of Pancreatic Cancer Surveillance in High-Risk Individuals
Journal of Gastrointestinal Cancer·2025· 2 citedOpen Access
Damaging mutations in liver X receptor-α are hepatotoxic and implicate cholesterol sensing in liver health
Nature Metabolism·2024· 13 citedOpen Access
<i>Ex-vivo</i> mouse precision cut tumour slices for modelling hepatocellular carcinoma; A 3Rs solution for at-scale drug screening
2024
Damaging mutations in LXR[alpha] uncouple lipogenesis from hepatotoxicity and implicate hepatic cholesterol sensing in human liver health
Endocrine Abstracts·2024
Integration of Germline Genetic Testing Into Routine Clinical Practice for Patients With Pancreatic Adenocarcinoma
JCO Oncology Practice·2024· 5 citedOpen Access
FRI-493 CLEC14A regulates neutrophil recruitment across liverendothelial cells and correlates with a neutrophil signature in hepatocellular carcinoma
Journal of Hepatology·2024
UCHL1-dependent control of hypoxia-inducible factor transcriptional activity during liver fibrosis
Bioscience Reports·2024· 3 citedOpen Access
Damaging mutations in LXRα uncouple lipogenesis from hepatotoxicity and implicate hepatic cholesterol sensing in human liver health
2024· 1 citedOpen Access
page 1 of 17Next →

Frequent Co-authors

Fiona Oakley(21), Jelena Mann(13), Caroline Wilson(9), Ahmed M. Elsharkawy(7), João F. Passos(6), Diana Jurk(6), Alastair D. Burt(5), Jack Leslie(5), Dina Tiniakos(4), Thomas von Zglinicki(4), Josep M. Llovet(4), Mathias Heikenwälder(4), Matthew C. Wright(4), John P. Iredale(4), J. Mann(4), Daniel Geh(4), Helen L. Reeves(4), María J. Perugorria(4), Quentin M. Anstee(3), Thomas G. Bird(3)